Cardiovascular Implications in Ischemic Stroke

Ischemic stroke, resulting from the obstruction of cerebral blood flow, precipitates not only focal brain injury but also a spectrum of acute and chronic cardiovascular disturbances. Acute cerebral ischaemia can trigger autonomic dysregulation, neuroendocrine activation and systemic inflammation, collectively termed the brain–heart axis, which may precipitate arrhythmias, blood-pressure lability and myocardial injury. Sympathetic overactivity and parasympathetic withdrawal drive haemodynamic instability, while prolonged inflammatory signalling and innate immune memory in monocytes and macrophages can promote cardiac fibrosis and long-term ventricular dysfunction. Biomarkers such as elevated cardiac troponins and hypoalbuminaemia have emerged as early predictors of adverse cardiac events and mortality following stroke. Recognition of these interlinked pathways underpins secondary prevention strategies, including continuous haemodynamic monitoring, targeted immunomodulatory therapies and optimisation of cardiovascular risk factors. Bridging mechanistic insights with clinical practice offers the potential to mitigate the global burden of post-stroke cardiac disease.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Research from all publishers

Recent studies have illuminated the immunological underpinnings of stroke-induced cardiac dysfunction. One investigation employing single-cell sequencing demonstrated that cerebral ischaemia establishes a persistent pro-inflammatory programme in monocytes and macrophages, driven by interleukin-1β-mediated epigenetic reprogramming. In experimental models, blockade of IL-1β or inhibition of CCR2/5-dependent monocyte trafficking prevented cardiac fibrosis and preserved ventricular function, suggesting a novel immunotherapy for secondary prevention.

A comprehensive review of brain–heart interplay has delineated key pathophysiological mechanisms—including hypothalamic–pituitary–adrenal axis activation, sympathetic and parasympathetic imbalance, systemic inflammation and gut dysbiosis—that collectively underlie post-stroke cardiovascular complications. Clinically, this crosstalk manifests as acute coronary syndromes, arrhythmias and heart failure. Current management focuses on blood-pressure control with agents such as labetalol and nicardipine, and on β-blockers to mitigate chronic remodelling, although definitive therapeutic targets remain to be established.

Large-scale analysis of electronic health records has revealed that patients presenting with reduced serum albumin at stroke onset exhibit a significantly higher risk of early cardiovascular events—including heart failure, myocardial infarction and arrhythmias—and all-cause mortality within 30 days. This association persists after adjustment for age, sex and comorbidity burden, highlighting hypoalbuminaemia as a readily available prognostic indicator and potential target for nutritional or anti-inflammatory interventions.

Cardiovascular Implications in Ischemic Stroke publication trend

The graph below shows the total number of articles in cardiovascular implications in ischemic stroke across all publications each year (not limited to Nature Index journals).

Technical terms

Ischemic stroke: Acute neurological deficit caused by occlusion of a cerebral artery leading to brain tissue hypoxia.

Brain–heart axis: Bidirectional communication network between the central nervous system and the cardiovascular system via autonomic, neuroendocrine and immune pathways.

Innate immune memory: Long-lasting epigenetic changes in innate immune cells that amplify inflammatory responses upon secondary injury.

Cardiac troponin: Cardiac-specific protein released into the circulation following myocardial injury, used as a biomarker for diagnosis and prognosis.

Hypoalbuminaemia: Abnormally low serum albumin concentration reflecting malnutrition or systemic inflammation and associated with worse clinical outcomes.

References

1. Innate immune memory after brain injury drives inflammatory cardiac dysfunction. Cell (2024).
2. Stroke Related Brain–Heart Crosstalk: Pathophysiology, Clinical Implications, and Underlying Mechanisms. Advanced Science (2024).
3. Albumin Levels and Risk of Early Cardiovascular Complications After Ischemic Stroke: A Propensity-Matched Analysis of a Global Federated Health Network. Stroke (2024).